We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$23.7B
AUM Growth
+$1.26B
Cap. Flow
+$2.43B
Cap. Flow %
10.25%
Top 10 Hldgs %
31.04%
Holding
1,328
New
56
Increased
716
Reduced
259
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$229M
2
MSFT icon
Microsoft
MSFT
+$208M
3
NVDA icon
NVIDIA
NVDA
+$198M
4
AMZN icon
Amazon
AMZN
+$197M
5
NOW icon
ServiceNow
NOW
+$193M

Sector Composition

Rank Sector Weight
1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
1151
DELISTED
Avadel Pharmaceuticals
AVDL
$3K ﹤0.01%
332
AVXL icon
1152
Anavex Life Sciences
AVXL
$231M
$3K ﹤0.01%
314
ELVN icon
1153
Enliven Therapeutics
ELVN
$3.78B
$3K ﹤0.01%
152
EOLS icon
1154
Evolus
EOLS
$397M
$3K ﹤0.01%
262
GMAB icon
1155
Genmab
GMAB
$17.5B
$3K ﹤0.01%
159
GRFS
1156
Grifois
GRFS
$5.55B
$3K ﹤0.01%
398
HROW icon
1157
Harrow
HROW
$1.44B
$3K ﹤0.01%
110
KNSA icon
1158
Kiniksa Pharmaceuticals
KNSA
$6.31B
$3K ﹤0.01%
139
NRIX icon
1159
Nurix Therapeutics
NRIX
$2.45B
$3K ﹤0.01%
245
SYRE icon
1160
Spyre Therapeutics
SYRE
$8.5B
$3K ﹤0.01%
+206
New +$4.29K
TXG icon
1161
10x Genomics
TXG
$5.88B
$3K ﹤0.01%
+370
New +$4.66K
VIR icon
1162
Vir Biotechnology
VIR
$1.46B
$3K ﹤0.01%
535
XLF icon
1163
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
$3K ﹤0.01%
67
-11
-14% -$552
ZYME icon
1164
Zymeworks
ZYME
$1.62B
$3K ﹤0.01%
286
GRAL
1165
GRAIL Inc
GRAL
$2.72B
$3K ﹤0.01%
98
ABSI icon
1166
Absci
ABSI
$1.17B
$2K ﹤0.01%
+600
New +$2.2K
ANAB icon
1167
AnaptysBio
ANAB
$1.54B
$2K ﹤0.01%
105
ARVN icon
1168
Arvinas
ARVN
$530M
$2K ﹤0.01%
252
CGEM icon
1169
Cullinan Oncology
CGEM
$1.06B
$2K ﹤0.01%
218
COGT icon
1170
Cogent Biosciences
COGT
$6.76B
$2K ﹤0.01%
416
CSTL icon
1171
Castle Biosciences
CSTL
$742M
$2K ﹤0.01%
86
CVAC
1172
DELISTED
CureVac
CVAC
$2K ﹤0.01%
697
DAWN
1173
DELISTED
Day One Biopharmaceuticals
DAWN
$2K ﹤0.01%
296
FTRE icon
1174
Fortrea Holdings
FTRE
$1.93B
$2K ﹤0.01%
328
IEUR icon
1175
iShares Core MSCI Europe ETF
IEUR
$8.8B
$2K ﹤0.01%
29

Similar funds

Daiwa Securities Group's Q1 2025 Portfolio in Review

As of Q1 2025, Daiwa Securities Group held 1,328 positions worth $23.7B, up 5.6% from $22.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $2.43B of net new capital in Q1 2025, opening 56 new positions and adding to 716 existing holdings. Its largest new stake was Autoliv: 89,727 shares worth $7.94M.

By sector, the portfolio is most concentrated in Real Estate at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was VICI Properties, an estimated $173M trimmed.

  • Daiwa Securities Group's largest Q1 2025 buy was Autoliv: 89,727 shares worth $7.94M.
  • Daiwa Securities Group added most to Apple in Q1 2025, an estimated $229M increase.
  • Daiwa Securities Group's biggest Q1 2025 reduction was VICI Properties, cutting an estimated $173M.
  • Daiwa Securities Group fully exited Global X SuperDividend REIT ETF in Q1 2025, selling an estimated $20.8M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $23.7B portfolio in Q1 2025.
  • Daiwa Securities Group opened 56 new positions and closed 49 in Q1 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $23.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.